AMP Study Explores Potency of Antibodies to Combat HIV Infection
Thursday, September 15, 2016 - 10:51
in Health & Medicine
A clinical trial underway - known as the AMP study (for Antibody Meditated Prevention) - will determine whether infusing an experimental antibody (VRC01) into HIV-negative men and transgender individuals who have sex with men, will prevent the acquisition of HIV.